# Navigating Ozempic: Addiction Trial, Vision Risk Warning & Ireland's Wegovy Decision (October 17, 2026)

**Breaking Ozempic and semaglutide news you need to know—from a potential addiction treatment breakthrough to a serious new eye condition warning.**

In this episode of Navigating Ozempic, we break down three major developments shaking up the semaglutide landscape:

🔬 **Addiction Treatment Trial**: Allegheny County, Pennsylvania is launching a $13.3 million clinical trial to study whether semaglutide can help treat alcohol and opioid use disorders. Learn how this 1,200-person, 52-week study could change addiction care—and why researchers urge caution before jumping to conclusions.

💶 **Ireland's Wegovy Access Decision**: Ireland's National Centre for Pharmacoeconomics has deemed Wegovy cost-effective for certain overweight patients, with a potential five-year price tag of €4.4 billion for the health system. We unpack what this means for obesity treatment access and the tough tradeoffs health systems face.

⚠️ **Critical Eye Safety Alert**: The European Medicines Agency has linked semaglutide to a rare but serious eye condition called NAION, which can cause sudden vision loss. We explain what the 1-in-10,000 risk estimate actually means, why Novo Nordisk disputes the findings, and what symptoms require immediate medical attention.

Plus: the truth behind "Ozempic face," emerging research on heart, kidney, and liver benefits, and why self-treating with unregulated semaglutide products is never worth the risk.

Whether you're currently taking Ozempic, Wegovy, or Rybelsus, considering treatment, or simply following the science, this episode delivers clear, evidence-based updates without the hype.

**Topics covered:** Ozempic news, semaglutide safety, Wegovy cost-effectiveness, NAION eye condition, addiction treatment research, weight loss medication side effects, GLP-1 drugs, diabetes treatment updates

🎧 Subscribe to Navigating Ozempic for weekly, fact-checked updates on the medicine changing modern healthcare.

*A Quiet Please production. Visit quietplease.ai for more.

Some great Deals https://amzn.to/49SJ3Qs

For more check out http://www.quietplease.ai

Podden och tillhörande omslagsbild på den här sidan tillhör Liquid Studios. Innehållet i podden är skapat av Liquid Studios och inte av, eller tillsammans med, Poddtoppen.